Literature DB >> 15806411

[Cardiovascular end organ impairment due to hypertension].

C M Schannwell1, S Steiner, M G Hennersdorf, B E Strauer.   

Abstract

Arterial hypertension is the most frequent cause of pressure overload on the left ventricle. Longer lasting arterial hypertension leads to hypertension-specific organ manifestations summarized as "hypertensive heart disease". Hypertensive heart disease comprise the manifestation of stenosis in epicardial arteries, hypertensive microvascular disease, ischemic cardiomyopathy, left ventricular hypertrophy, endothelial dysfunction, increased sympathetic drive and degeneration of aortic valve. Diastolic dysfunction and reduced coronary flow reserve can be evaluated as early markers of hypertensive heart disease. These alterations lead to the major clinical manifestations of hypertensive heart disease that are symptoms of reduced coronary insufficiency with typical angina pectoris, but also of symptoms of heart failure (systolic and diastolic dysfunction) and arrhythmia. Different non-invasive and invasive procedures are available for screening and follow-up of patients with hypertensive heart disease. Primary therapeutic target is, apart from lowering blood pressure, to reverse cardiac manifestations of arterial hypertension using specific therapeutic algorithms.

Entities:  

Mesh:

Year:  2005        PMID: 15806411     DOI: 10.1007/s00108-005-1394-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  46 in total

Review 1.  New insights and approaches to reduce end-organ damage in the treatment of hypertension: subsets of hypertension approach.

Authors:  M C Houston
Journal:  Am Heart J       Date:  1992-05       Impact factor: 4.749

2.  Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption.

Authors:  U E Heidland; B E Strauer
Journal:  Circulation       Date:  2001-09-25       Impact factor: 29.690

3.  Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

Authors:  T Nishikimi; F Yoshihara; A Morimoto; K Ishikawa; T Ishimitsu; Y Saito; K Kangawa; H Matsuo; T Omae; H Matsuoka
Journal:  Hypertension       Date:  1996-07       Impact factor: 10.190

4.  Repair of coronary arterioles after treatment with perindopril in hypertensive heart disease.

Authors:  B Schwartzkopff; M Brehm; M Mundhenke; B E Strauer
Journal:  Hypertension       Date:  2000-08       Impact factor: 10.190

Review 5.  Heart failure on the basis of hypertension.

Authors:  B Schwartzkopff; W Motz; M Vogt; B E Strauer
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

6.  Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension.

Authors:  Y Shigematsu; M Hamada; M Mukai; H Matsuoka; T Sumimoto; K Hiwada
Journal:  J Hypertens       Date:  1995-01       Impact factor: 4.844

7.  Electrophysiologic consequences of chronic experimentally induced left ventricular pressure overload.

Authors:  J S Cameron; R J Myerburg; S S Wong; M S Gaide; K Epstein; T R Alvarez; H Gelband; P A Guse; A L Bassett
Journal:  J Am Coll Cardiol       Date:  1983-09       Impact factor: 24.094

8.  Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study.

Authors:  D Levy; D D Savage; R J Garrison; K M Anderson; W B Kannel; W P Castelli
Journal:  Am J Cardiol       Date:  1987-04-15       Impact factor: 2.778

Review 9.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

10.  Prevalence and determinants of cardiac and vascular hypertrophy in hypertension.

Authors:  M J Roman; T G Pickering; R Pini; J E Schwartz; R B Devereux
Journal:  Hypertension       Date:  1995-08       Impact factor: 10.190

View more
  3 in total

1.  Angina Relief by Ranolazine Identifies False-Negative SPECT Myocardial Perfusion Scans in Patients with Coronary Disease Demonstrated by Coronary Angiography.

Authors:  Gary L Murray
Journal:  Int J Angiol       Date:  2014-09

Review 2.  [Hypertension and cardiac failure].

Authors:  C M Schannwell; M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2007-09       Impact factor: 0.743

3.  The prevalence of supraventricular arrhythmias with regard to the type and degree of left ventricular hypertrophy in patients with hypertensive heart disease.

Authors:  Juraj Kunisek; Luka Zaputovic; Marta Zuvic Butorac; Leon Kunisek; Ksenija Lukin-Eskinja; Rade Karlavaris; Irena Bruketa-Markic
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.